Angela Ogden, PhD
Angela Ogden, PhD
Verified email at
Cited by
Cited by
HSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms in breast cancer patients
V Pannu, PCG Rida, A Ogden, RC Turaga, S Donthamsetty, NJ Bowen, ...
Oncotarget 6 (8), 6076, 2015
Let's huddle to prevent a muddle: centrosome declustering as an attractive anticancer strategy
A Ogden, PCG Rida, R Aneja
Cell Death & Differentiation 19 (8), 1255-1267, 2012
The Noscapine Chronicle: A Pharmaco‐Historic Biography of the Opiate Alkaloid Family and its Clinical Applications
PCG Rida, D LiVecche, A Ogden, J Zhou, R Aneja
Medicinal research reviews 35 (5), 1072-1096, 2015
Heading off with the herd: how cancer cells might maneuver supernumerary centrosomes for directional migration
A Ogden, PCG Rida, R Aneja
Cancer and Metastasis Reviews 32 (1-2), 269-287, 2013
KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries
S Pawar, S Donthamsetty, V Pannu, P Rida, A Ogden, N Bowen, R Osan, ...
Journal of ovarian research 7 (1), 53, 2014
Docetaxel-induced polyploidization may underlie chemoresistance and disease relapse
A Ogden, PCG Rida, BS Knudsen, O Kucuk, R Aneja
Cancer letters 367 (2), 89-92, 2015
Microtubule‐Binding Proteins as Promising Biomarkers of Paclitaxel Sensitivity in Cancer Chemotherapy
S Xie, A Ogden, R Aneja, J Zhou
Medicinal research reviews 36 (2), 300-312, 2016
Interphase microtubules: chief casualties in the war on cancer?
A Ogden, PCG Rida, MD Reid, R Aneja
Drug discovery today 19 (7), 824-829, 2014
Centrosome-declustering drugs mediate a two-pronged attack on interphase and mitosis in supercentrosomal cancer cells
V Pannu, PCG Rida, B Celik, RC Turaga, A Ogden, G Cantuaria, ...
Cell death & disease 5 (11), e1538, 2014
Induction of robust de novo centrosome amplification, high-grade spindle multipolarity and metaphase catastrophe: a novel chemotherapeutic approach
V Pannu, PCG Rida, A Ogden, R Clewley, A Cheng, P Karna, M Lopus, ...
Cell death & disease 3 (7), e346, 2012
Quantitative multi-parametric evaluation of centrosome declustering drugs: centrosome amplification, mitotic phenotype, cell cycle and death
A Ogden, A Cheng, PCG Rida, V Pannu, R Osan, R Clewley, R Aneja
Cell death & disease 5 (5), e1204, 2014
Mitochondrial genome regulates mitotic fidelity by maintaining centrosomal homeostasis
S Donthamsetty, M Brahmbhatt, V Pannu, P Rida, S Ramarathinam, ...
Cell Cycle 13 (13), 2056-2255, 2014
Centrosome amplification: a suspect in breast cancer and racial disparities
A Ogden, PCG Rida, R Aneja
Endocrine-Related Cancer, ERC-17-0072, 2017
Diverse roles of HDAC6 in viral infection: Implications for antiviral therapy
L Zhang, A Ogden, R Aneja, J Zhou
Pharmacology & therapeutics 164, 120-125, 2016
Amplified centrosomes may underlie aggressive disease course in pancreatic ductal adenocarcinoma
K Mittal, A Ogden, MD Reid, PCG Rida, S Varambally, R Aneja
Cell Cycle 14 (17), 2798-2809, 2015
Multi-institutional study of nuclear KIFC1 as a biomarker of poor prognosis in African American women with triple-negative breast cancer
A Ogden, C Garlapati, XB Li, RC Turaga, G Oprea-Ilies, N Wright, ...
Scientific Reports 7, 42289, 2017
Prognostic value of CA20, a score based on centrosome amplification-associated genes, in breast tumors
A Ogden, PCG Rida, R Aneja
Scientific Reports 7, 2017
Die-hard survivors: heterogeneity in apoptotic thresholds may underlie chemoresistance
A Ogden, PCG Rida, MD Reid, O Kucuk, R Aneja
Expert review of anticancer therapy 15 (3), 277-281, 2015
Nuclear HSET, a predictor for metastasis, disease relapse, and poor survival, is a racial disparity biomarker in triple-negative breast cancer patients
A Ogden, G Oprea-Ilies, PCG Rida, D Nickleach, Y Liu, G Cantuaria, ...
A combined HER3-EGFR score in triple-negative breast cancer: racial differences.
A Ogden, S Bhattarai, N Wright, S Klimov, S Pattni, M Aleskandarany, ...
Journal of Clinical Oncology 34 (15_suppl), e12560-e12560, 2016
The system can't perform the operation now. Try again later.
Articles 1–20